Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05076708 · ClinicalTrials.gov registry record · Early Phase 1
The Effects of IQOS Use on Cigarette Smoking Behaviors
A Early Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 102
- Enrollment target
NCT05076708: Completed Early Phase 1 study, sponsored by University of Pennsylvania.
NCT05076708 is a Early Phase 1 study that has completed, run by University of Pennsylvania. The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05076708, a Early Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 102 participants
- Enrollment target
Study Summary
This within-subjects study aims to evaluate the effects of IQOS use on combustible cigarette smoking behaviors among 100 cigarette smokers who completed the study. After measuring baseline cigarette smoking rate, participants will receive an IQOS device and be instructed to use it (versus cigarettes) over a 14-day period. The investigators will also examine which objective and subjective effects of IQOS use predict a complete and incomplete switch from cigarettes to IQOS.
Interventions
- OTHER IQOS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2021-08-26 |
| Est. Completion | 2024-05-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05076708
The ClinicalTrials.gov registry entry for NCT05076708 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IQOS is the first listed.
NCT05076708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05076708 about?
NCT05076708 is a clinical study titled "The Effects of IQOS Use on Cigarette Smoking Behaviors". This within-subjects study aims to evaluate the effects of IQOS use on combustible cigarette smoking behaviors among 100 cigarette smokers who completed the study. After measuring baseline cigarette smoking rate, participants will receive an IQOS device and be instructed to use it (versus cigarettes...
What is the current status of trial NCT05076708?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 102 participants. The study started on 2021-08-26. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05076708?
The interventions under investigation include: IQOS (OTHER).
Who is sponsoring clinical trial NCT05076708?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.